Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
about
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVHeterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsIsolation of monoclonal antibodies with predetermined conformational epitope specificityCo-immunization with multimeric scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cellsSolution structure, conformational dynamics, and CD4-induced activation in full-length, glycosylated, monomeric HIV gp120Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoproteinUpdate on animal models for HIV research.Phages and HIV-1: from display to interplay.Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody.Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.Novel biopanning strategy to identify epitopes associated with vaccine protection.Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesLive-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virusRecombinant production of influenza hemagglutinin and HIV-1 GP120 antigenic peptides using a cleavable self-aggregating tag.Display of the HIV envelope protein at the yeast cell surface for immunogen development
P2860
Q27349203-1658FE3A-2989-4977-9059-37A4B00A8BFEQ28394899-35442C6A-5FFB-4D67-B324-E2F00029462DQ28728170-F70EA128-389F-4F1B-BE2D-44DD6386A8EEQ28732043-9ABCE5B9-60AF-4CA1-B03D-318D7B0428F9Q30524225-5927084B-01B5-45D0-9813-4FCD8649E57FQ33518005-5A33D102-4A43-4F91-A7AF-FD4D0A5ED813Q33522232-3434894E-0D8F-4A45-A6CC-3D328055E84BQ33835488-C8724206-66F1-49DA-87E1-C2B732E41851Q34273397-E5FD0849-D2FB-427F-849E-D6D11D44025BQ34283442-B462F82F-59D3-4C67-BA5A-234C12E5E80CQ34488183-7BCCEAD1-3B78-467A-A022-19786344B11BQ34579037-545D65C2-AEC8-40C5-8337-2BD3E59DFD9DQ34625185-24D50418-0E85-4DD8-BF7A-67C1D672632AQ34774808-F2623AB8-94AA-4B25-8FD6-2EED27D749BCQ36964284-D9C9FEAC-64CA-4A6E-B0EB-8758A0E4D089Q37287933-1B729AE5-406F-4259-B6FC-56771267EAD6Q37390576-CB2AA163-C513-47CF-9643-044B35D91613Q58601813-9F9F9FAB-DED2-4267-B3C2-A90AA6D1D2B0
P2860
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@ast
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@en
type
label
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@ast
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@en
prefLabel
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@ast
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@en
P2093
P2860
P1433
P1476
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing
@en
P2093
Fabian M P Kaiser
Helena Ong
Michael Humbert
Robert A Rasmussen
Ruth M Ruprecht
Shiu-Lok Hu
P2860
P356
10.1371/JOURNAL.PONE.0003937
P407
P577
2008-12-15T00:00:00Z